Membranoproliferative glomerulonephritis epidemiology and demographics: Difference between revisions
| Line 8: | Line 8: | ||
== Correlation of age and sex with glomerular disease == | == Correlation of age and sex with glomerular disease == | ||
Due to the pathophysiology of glomerular disease, incidence of most of the glomerular disease is in middle-age group. Albeit there are some categorizes that could occurred during childhood. | Due to the pathophysiology of glomerular disease, incidence of most of the glomerular disease is in middle-age group. Albeit there are some categorizes that could occurred during childhood. | ||
{| style="border: 3px; margin: 1px; font-size: 90%; width: 700px; align=" center " | |||
! colspan="6" style="background: #5579ff; width 700px; " | {{fontcolor|#FFF|Age-adjusted trends in patient demographics among patients with specified glomerular disease diagnoses*}} | |||
|- | |||
! colspan="2" style="background: #4479ba; " | {{fontcolor|#FFF| demographic variables}} | |||
! style="background: #4479ba; " | {{fontcolor|#FFF| 1986-1995, %}} | |||
! style="background: #4479ba; " | {{fontcolor|#FFF| 1996-2005, %}} | |||
! style="background: #4479ba; " | {{fontcolor|#FFF| 2006-2015, %}} | |||
! style="background: #4479ba; " | {{fontcolor|#FFF| Total, %}} | |||
|- | |||
! rowspan="3" style="padding: 4px 4px; background: #00AF89; " | {{fontcolor|#FFF| Gender}} | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Male | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 51.9 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 50.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 51.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 50.8 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Female | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 48 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 49.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 48.8 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 48.9 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | missing sex | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.8 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.3 | |||
|- | |||
! rowspan="5" style="padding: 4px 4px; background: #00AF89; " | {{fontcolor|#FFF| Race}} | |||
! style="padding: 3px 3px; background: #B0E0E6; " | White | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 64.1 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 56.5 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 54.7 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 56.8 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Black | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 34.5 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 39.9 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 38.2 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 38.3 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Latino | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.6 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 1.8 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 4.2 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 2.8 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Asian | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.0 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 1.0 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 2.0 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 1.4 | |||
|- | |||
! style="padding: 3px 3px; background: #B0E0E6; " | Other | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.8 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.6 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.9 | |||
! style="padding: 3px 3px; background: #E0FFFF; " | 0.8 | |||
|- | |||
! colspan="6" style="background: #5579ff; width 700px; " | {{fontcolor|#FFF|*These are datas for USA population}} | |||
|} | |||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
Revision as of 07:01, 22 July 2018
Overview
Since Membranoproliferative Glomerulonephritis (MPGN) is a small portion of all glomerular disease, there is not enough evidence to completely demonstrate the epidemiology of this specific category.
Albeit, there are strong valid studies demonstrate the incidence and prevalence of all glomerular diseases.
Correlation of age and sex with glomerular disease
Due to the pathophysiology of glomerular disease, incidence of most of the glomerular disease is in middle-age group. Albeit there are some categorizes that could occurred during childhood.
| Age-adjusted trends in patient demographics among patients with specified glomerular disease diagnoses* | |||||
|---|---|---|---|---|---|
| demographic variables | 1986-1995, % | 1996-2005, % | 2006-2015, % | Total, % | |
| Gender | Male | 51.9 | 50.1 | 51.1 | 50.8 |
| Female | 48 | 49.1 | 48.8 | 48.9 | |
| missing sex | 0.1 | 0.8 | 0.1 | 0.3 | |
| Race | White | 64.1 | 56.5 | 54.7 | 56.8 |
| Black | 34.5 | 39.9 | 38.2 | 38.3 | |
| Latino | 0.6 | 1.8 | 4.2 | 2.8 | |
| Asian | 0.0 | 1.0 | 2.0 | 1.4 | |
| Other | 0.8 | 0.6 | 0.9 | 0.8 | |
| *These are datas for USA population | |||||
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis epidemiology and demographics |
|
FDA on Membranoproliferative glomerulonephritis epidemiology and demographics |
|
CDC on Membranoproliferative glomerulonephritis epidemiology and demographics |
|
Membranoproliferative glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranoproliferative glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |